Month: May 2023

Company announcement no. 28 Net profit of DKK 557 million and return on equity of 19.5% The financial statements for the first quarter of 2023 show a highly satisfactory net profit of DKK 557 million and a return on equity of 19.5%. The Bank’s core income was lifted by strong growth in net interest income driven by rising policy and market rates and the implementation of interest rate changes on the Bank’s deposit and loan products. Business volume growth and buoyant financial markets also contribute favourably to the overall financial performance. On the other hand, the Bank recorded lower net fee income in Q1 2023 due to a lower level of activity in house sales and mortgage credit facilitation as well as in securities trading and asset management. Towards the end of Q1 2023, the collapse and subsequent rescue of two US banks and Switzerland-based...

Stellantis Reports 14% Increase in Q1 2023 Net Revenues,All Segments Contributing PositivelyNet revenues of €47.2 billion, up 14% compared to Q1 2022 mainly due to higher shipments and strong net pricing Consolidated shipments(1) of 1,476 thousand units, up 7% primarily due to improvement in semiconductor order fulfillment versus Q1 2022 Total new vehicle inventory of 1,302 thousand units at March 31, 2023, reflecting a return to normal inventory levels; includes Company inventory of 384 thousand units Ordinary dividend of €1.34 per share approved at AGM to be paid to shareholders on May 4, 2023 €1.5 billion stock buyback initiated, first €500 million tranche expected to be completed in June 2023 Global BEV sales increased 22% versus Q1 2022; ongoing global focus with 9 new BEVs launching in 2023“Stellantis is off to a solid start...

Focus on executing the strategic plan and delivering shareholder value MDG1015 pre-clinical data underline potential in solid tumor therapy Subsequent to Q1, expansion of tools and technologies in our end-to-end technology platform Guidance confirmed; cash runway maintained through Q4 2024Martinsried/Munich, May 3, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today reported financial results for the first quarter of 2023. The full Quarterly Statement Q1 2023 can be downloaded here: https://medigene.com/investors-media/reports-presentations/ “Since the beginning of 2023, we have been making significant progress on our strategy in addressing the unmet needs in treating solid tumors. We have expanded the...

Financial highlightsBrand registers its fourth consecutive quarter of resilient growth despite the macroeconomic challenges. Q1 2023 organic growth at 1% and like-for-like (LFL) at 0%. LFL in key markets in Europe sequentially improves to 0%, US remains at -7% as in Q4 and Rest of Pandora remains strong at 12%. Network expansion drives 3% growth and generates strong margins. Gross margins continue the upward trend witnessed over past years and reach 77.5%, +1.5pp vs. Q1 2022.  Pricing actions, channel mix and commodity tailwinds contribute positively. As expected, EBIT margin at 21.5% down 1.5pp vs. Q1 2022 reflecting a.o. revenue and cost phasing. Full-year EBIT margin to be broadly in line with last year. Leverage remains low with NIBD/EBITDA at 1.2x. DKK 1.5 billion of share buyback program completed. Assuming no material macroeconomic...

In Q1 2023 Inbank earned a consolidated net profit of 1.9 million euros decreasing 37% year-on-year. The return on equity was 7.3%.Inbank’s loan and subscription portfolio increased by 26% compared to Q1 2022 reaching 856 million euros. The deposit portfolio grew 27% and reached 857 million euros by the end of Q1. At the end of Q1 2023, Inbank’s total assets stood at 1.05 billion euros. Gross merchandise value (GMV) during the first quarter was 155 million euros, which is 14% more than a year ago. GMV through our merchant solutions grew by 15% reaching 68 million. The strongest growth was recorded by our car finance business, where GMV grew 65% to 32 million euros. Subscriptio solutions also showed strong annual growth of 29%, reaching 13 million euros, while direct lending GMV grew 20% and reached 21 million. Because of higher interest...

Lassila & Tikanoja plc Stock exchange release 3 May 2023 at 8:00 a.m. Lassila & Tikanoja plc: Interim Report 1 January–31 March 2023 THE PROFIT PERFORMANCE OF FACILITY SERVICES FINLAND IMPROVED Unless otherwise mentioned, the figures in brackets refer to the corresponding period in the previous year.Net sales for the first quarter were EUR 192.7 million (210.4). Net sales decreased by 8.4%, mainly due to the divestment of the renewable energy sources business in the previous financial year. Net sales growth excluding the renewable energy sources business was 2.9%. Adjusted operating profit was EUR 1.4 million (0.0) and operating profit was EUR 1.4 million (-0.3). Earnings per share were EUR 0.03 (-0.02). Net cash flow from operating activities after investments per share was strong at EUR 0.50 (-0.16). The result of Facility...

Company announcement no. 8 / 2023 Schindellegi, Switzerland – 3 May 2023Trifork Group – Report of the first quarter ending 31 March 2023Trifork Group: Solid performance in the core business and maintained full–year guidanceFinancial results in the first quarter of 2023 Trifork GroupTrifork Group revenue amounted to EURm 49.7, an increase of 8.5% from Q1/2022. Revenue growth was 16.1%, of which 13.9%-points was organic growth, when adjusting for aperiodic sales of third-party software and hardware. Trifork Group EBITDA amounted to EURm 8.1, corresponding to a 16.4% EBITDA margin and a growth of 5.0%. Trifork Group EBIT amounted to EURm 5.0, corresponding to a 10.1% EBIT margin and a growth of 5.9%. Trifork Group net income amounted to EURm 2.9, resulting in a basic earnings per share of EUR 0.10.Trifork SegmentAdjusted EBITDA...